Which statement is true for a patient with hypertension treated with irbesartan and hydrochlorothiazide, osteoporosis treated with calcium and vitamin D, presenting with weakness, vomiting, acute kidney injury, and severe hypercalcemia?

The patient is dehydrated due to vomiting and polyuria caused by the hypercalcemia (Answer E)

This patient presents with severe hypercalcemia (14 mg/dL), acute kidney injury (creatinine 2 mg/dL), and symptoms of weakness and vomiting—a clinical picture consistent with dehydration from both vomiting and hypercalcemia-induced polyuria. 1

Clinical Reasoning

Why Dehydration is the Correct Answer

Severe hypercalcemia (≥14 mg/dL or 3.5 mmol/L) causes nephrogenic diabetes insipidus by impairing the kidney's ability to concentrate urine, leading to polyuria 1. This, combined with vomiting-induced fluid losses, creates a vicious cycle:

• Hypercalcemia → Polyuria → Volume depletion → Reduced GFR → Worsening hypercalcemia
• The acute kidney injury (creatinine 2 mg/dL) reflects this volume depletion and reduced renal perfusion
• Dehydration with acute renal failure is specifically recognized as a severe clinical manifestation requiring critical care admission 1

Why the Other Options are Incorrect

Option A (Hypercalcemia due solely to calcium/vitamin D): While calcium and vitamin D supplementation contributes, this ignores the critical role of hydrochlorothiazide in this presentation. Thiazide diuretics enhance renal tubular calcium reabsorption, significantly increasing hypercalcemia risk 2, 3, 4, 5. This is likely calcium-alkali-thiazide syndrome (CATS)—a well-documented triad of hypercalcemia, acute kidney injury, and metabolic alkalosis in patients taking calcium supplements with thiazide diuretics 2, 3.

Option B (Vomiting caused metabolic acidosis): This is physiologically incorrect. Vomiting causes metabolic alkalosis (not acidosis) due to loss of gastric hydrochloric acid. In fact, metabolic alkalosis is part of the CATS triad 2, 6. Additionally, alkalosis worsens hypercalcemia symptoms by increasing the ionized calcium fraction, not the reverse.

Option C (Magnesium level will help investigate etiology): While magnesium abnormalities can affect PTH secretion 7, 8, checking magnesium is not the primary diagnostic step here. The clinical picture clearly points to medication-induced hypercalcemia (calcium/vitamin D/thiazide combination). Magnesium would be more relevant in evaluating hypoparathyroidism or refractory hypocalcemia, not this presentation.

Option D (Patient not taking medications because no hyperkalemia): This reasoning is flawed. Irbesartan (an ARB) does reduce aldosterone and can cause hyperkalemia 9, 10, but hydrochlorothiazide causes hypokalemia by increasing renal potassium excretion 11. These opposing effects often balance out, resulting in normal potassium levels. The absence of hyperkalemia does not indicate medication non-adherence.

Immediate Management Priorities

For severe symptomatic hypercalcemia with acute kidney injury 1, 12:

1. Aggressive IV saline hydration (first-line treatment)

   • Volume expansion during first 24 hours, adapted to cardiac/renal function
   • Continues until calcium normalizes

2. Discontinue offending medications

   • Stop calcium and vitamin D supplements
   • Discontinue hydrochlorothiazide (critical contributor)

3. Consider IV bisphosphonates (zoledronate or pamidronate) after initial hydration

   • Indicated for severe hypercalcemia to lower calcium and prevent complications
   • Doses must be adjusted for renal function 1

4. Monitor closely

   • Serial calcium, creatinine, electrolytes
   • Assess for cardiac arrhythmias (ECG monitoring)

Key Clinical Pitfall

The combination of calcium/vitamin D supplementation with thiazide diuretics creates a perfect storm for severe hypercalcemia 2, 3, 4, 5. Thiazides are often overlooked as contributors because they're considered "routine" antihypertensives. In patients requiring calcium supplementation (osteoporosis, hypoparathyroidism), alternative antihypertensives should be strongly considered, or calcium levels must be monitored very closely if thiazides are continued.